Atlas Trials

To Assess the Bioavailability and Safety of Paclitaxel Injection Concentrate for Suspension in Subjects With Locally Recurrent or Metastatic Breast Cancer

Clinical trial NCT04332549 · WITHDRAWN

Trial details

NCT number
NCT04332549
Sponsor
Sun Pharma Advanced Research Company Limited
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Breast CancerLocally Recurrent Cancer
Start date
2020-04-27
Primary completion
2021-01-28
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.